MedPath

Can MicroRNA's Predict Multicentricity in Breast Cancer?

Not Applicable
Completed
Conditions
Multicentric Breast Cancer
Interventions
Genetic: miRNA
Registration Number
NCT04516330
Lead Sponsor
Bezmialem Vakif University
Brief Summary

The aim of this study is to determine if microRNA's have role in predicting multicentricity in breast cancer. If a specific microRNA will be found to be related with multicentricity, it will help us to make appropriate decisions on the treatment of patients with multicentric breast cancer.

Detailed Description

In the study that will be held at Bezmialem Vakif University Medical Faculty, General Surgery Department, 20 unifocal and 20 multifocal breast cancer patients will be included. Tissues will be taken from both tumoral and normal breast tissues and they will be saved in microRNA later solution under -80°C. Then, 84 microRNA's will be studied in these tissues to see if they express any of these microRNA's.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
57
Inclusion Criteria
  1. Having breast cancer
  2. Having no other malignancy
  3. Female patient
Exclusion Criteria
  1. Having other malignancy
  2. Under 18 years old
  3. Male patient

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
unifocal breast cancermiRNApatients having unifocal breast cancer
multicentric breast cancermiRNApatients having multicentric breast cancer
Primary Outcome Measures
NameTimeMethod
MicroRNA's in multicentric breast cancerApril 2014

Evaluation of 84 microRNA's in patients with multicentric breast cancer

Secondary Outcome Measures
NameTimeMethod
Treatment plan according to the detected microRNA in patients with multicentric breast cancerApril 2014

If a specific microRNA will be detected in patients with multicentric breast cancer, treatment plan will be individualized according to the detected microRNA

Trial Locations

Locations (1)

Bezmialem Vakif University

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath